Please call your physician’s office before coming in for your appointment if you have symptoms of a cough, fever, or difficulty breathing; traveled to Europe or China or other areas impacted by the coronavirus (COVID-19) within the past 14 days; been in close contact with someone who has traveled outside the U.S. to one of the impacted countries; or may have been exposed to the coronavirus. Effective Monday May 18th all VCS sites will be conducting temperature checks for all patients and visitors at entrances. For your safety, you will be asked to use a mask, if you do not have one, a mask will be provided. If a person presents with a temperature, you will be asked to return home and further instructions will be given by your health care team. For our patients protection, no visitors under 18 will be allowed in the offices, there is a limit one (1) visitor per patient if necessary. No visitors are allowed in the chemo infusion room. Our new office hours are: Monday through Friday 8:30 a.m. to 4:00 p.m, if you have an appointment scheduled for after hours, our office will be contacting you directly to reschedule. FOR THE LATEST UP TO DATE INFORMATION, ALERTS AND CANCELLATIONS PLEASE CLICK HERE

Co Author Alex Spira, MD - Lung Cancer Study Treatment Option for ALK Positive Lung Cancer Patients

Virginia Cancer Specialists Practice Blog

September 25, 2018
Virginia Cancer Specialists » VCS Practice News » Physicians » VCS Practice News » Alex Spira MD PhD FACP » Co Author Alex Spira, MD – Lung Cancer Study Treatment Option for ALK Positive Lung Cancer Patients

Co Author Alex Spira, M.D., PhD, F.A.C.P. @AlexSpiraMDPhD – Congratulations tor our Virginia Cancer Specialists Research Team on contributing to the lung cancer literature, and most importantly another treatment option for our patients with ALK positive lung cancer! Reminds us why we work so hard to give our patients access to research. #CancerResearch #CancerTrials

See the Study Here:

Brigatinib versus Crizotinib in ALK-Positive Non–Small-Cell Lung Cancer | NEJM